The Efficacy and Adverse Effects of Favipiravir on COVID-19 Patients: A Systematic Review and Meta-Analysis of Published Clinical Trials and Observational Studies
SSRN Electronic Journal2021
Citations Over Time
Dang The Hung, Suhaib Ghula, Jeza Muhamad Abdul Aziz, Abdelrahman M Makram, Gehad Mohamed Tawfik, Ali Ahmed‐Fouad Abozaid, Rohan Pancharatnam, Amr Mohamed Ibrahim, Muhammad Besher Shabouk, Morgan Turnage, Saloni Nakhare, Zahra Karmally, Basel Kouz, Tran Le, Suleiman Alhijazeen, Nguyen Quoc Phuong, Alaa Mohamed Ads, Ali Hussein Abdelaal, Nguyen Hai Nam, Tatsuo Iiyama, Kyoshi Kita, Kenji Hirayama, Nguyen Tien Huy
Related Papers
- → Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase(2017)1,075 cited
- → Favipiravir and COVID-19: A Simplified Summary(2020)99 cited
- → Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir(2016)70 cited
- → FAVIPIRAVIR AS A POTENTIAL DRUG IN THE TREATMENT OF COVID-19(2020)6 cited
- → Favipiravir: Promising Therapy for COVID-19(2020)